Concepedia

Douglas E. Faries

DE

95

Publications

7.2K

Citations

43

H-Index

1993

Active since

Affiliations

Eli Lilly (United States)(Current)

Massachusetts General Hospital

Duke Medical Center

Indiana University – Purdue University Indianapolis

University of Nebraska Medical Center

Douglas E. Faries is an author at Eli Lilly (United States) specializing in medicine, psychiatry, and social sciences.

ORCID

Top concepts

Publications per year

1993–2022

95

Publications

95

Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

David Michelson, Douglas E. Faries, Joachim Wernicke et al. · PEDIATRICS · 2001 · 668 citations

Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care

Haya Ascher‐Svanum, Douglas E. Faries, Baojin Zhu et al. · The Journal of Clinical Psychiatry · 2006 · 476 citations

Results From 2 Proof-of-Concept, Placebo-Controlled Studies of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Thomas Spencer, John H. Heiligenstein, Joseph Biederman et al. · The Journal of Clinical Psychiatry · 2002 · 336 citations

Relapse Prevention in Pediatric Patients With ADHD Treated With Atomoxetine: A Randomized, Double-Blind, Placebo-Controlled Study

David Michelson, Jan K. Buitelaar, Marina Danckaerts et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2004 · 306 citations

, , +11

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

Víctor Pérez, Inmaculada Gilaberte, Douglas E. Faries et al. · The Lancet · 1997 · 299 citations

, , +6

Rows per page

1–5 of 95